About ISS and CR

Collaborative Research & Investigator Sponsored Studies submissions

An Investigator Sponsored Study (ISS) is one in which the Investigator assumes responsibility, both as an investigator and a sponsor, for all aspects of the investigation including:

• Trial design
• Ensuring appropriate institutional and regulatory approval
• Study conduct, including responsibility for ensuring appropriate medical safeguards, medical monitoring, and medical supervision
• Analysis and interpretation of the results
• Communication of the results (e.g., publications)

Collaborative Research (CR) provides mechanism for industry and non-industry partners to conduct research in a risk-sharing manner. In Collaborative Research, instead of being limited to providing funding and/or product, Teva Pharmaceuticals contributes expertise complementary to that of the non-industry partner, who is the sponsor of the study

For consideration, all requests must have the required documentation. Should you require assistance please contact your Teva Medical Affairs representative.

For current information and updates on the disease states and therapeutic areas of interest to Teva, please review our Theraputic Areas Tab here.

No, the Teva Investigator Sponsored Studies (ISS) and Collaborative Research Program (CR) considers submissions of original research only.